Vivian W. Gu

Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas

Maria V. Bogachek, Jung M. Park, James P. De Andrade et al. · Stem Cell Reports · 2016 · 70 citations · Full text

EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib

James P. De Andrade, Jung M. Park, Vivian W. Gu et al. · Molecular Cancer Therapeutics · 2016 · 36 citations · Full text

Breast Oncology, Oncology, Egfr Is +15

TFAP2C regulates carbonic anhydrase XII in human breast cancer

Christopher Franke, Vivian W. Gu, Benjamin G. Grimm et al. · Oncogene · 2019 · 33 citations

Tumor Biology, Breast Oncology, Biochemistry +8

AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer

Anna C. Beck, Edward H. Cho, Jeffrey R. White et al. · Molecular Cancer Research · 2021 · 19 citations · Full text

Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer

James P. De Andrade, Allison W. Lorenzen, Vincent T. Wu et al. · Oncotarget · 2017 · 18 citations · Full text